Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells

Nature

Volumn 398, Issue 6725, 1999, Pages 341-344

  Kurts, Christian ^a   Carbone, Francis R ^b   Krummel, Matthew F ^c   Koch, Karl M ^a   Miller, Jacques F A P ^c   Heath, William R ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD30 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CROSS TOLERANCE; DIABETES MELLITUS; EFFECTOR CELL; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD30; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CLONAL DELETION; DIABETES MELLITUS, TYPE 1; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; SIGNAL TRANSDUCTION; TRANSPLANTATION CHIMERA;

ANIMALIA;

EID: 0033602420     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/18692     Document Type: Article

References (23)

1. + T cells J Exp Med. 186, 239-245 (1997)
2. Heath, W. R., Kurts, C., Miller, J. F. A. P. & Carbone, F. R. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 187, 1549-1553 (1998).
3. Kurts, C., Heath, W. R., Kosaka, H., Miller, J. F. A. P. & Carbone, F. R. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signalling through CD95 (Fas, Apo-1). J. Exp. Med. 188, 415-420 (1998).
4. Schwab, U. et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299, 65-67 (1982).
5. Schwarting, R. et al. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74, 1678-1689 (1989).
6. Bowen, M. A., Lee, R. K., Miragliotta, G., Nam, S. Y., & Podack, E. R. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156, 442-449 (1996).
7. Telford, W. G., Nam, S. Y., Podack, E. R. & Miller, R. A. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals. Cell. Immunol. 182, 125-136 (1997).
8. Gilfillan, M. C., Noel, P. J., Podack, E. R., Reiner, S. L & Thompson, C. B. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. J. Immunol. 160, 2180-2187 (1998).
9. Bowen, M. A., Olsen, K. J., Cheng, L., Avila, D. & Podack, E. R. Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD2B and IL-2R, and induction of homotypic aggregation. J. Immunol. 151, 5896-5906 (1993).
10. Lee, S. Y. et al. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Proc. Natl Aced. Sci. USA 93, 9699-9703 (1996).
11. Lee, S. Y., Park, C. G. & Choi, Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183, 669-674 (1996).
12. Hamann, D. et al. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J. Immunol. 156, 1387-1391 (1996).
13. Amakawa, R. et al. Impaired negative selection of T cells in Hodgkins disease antigen CD30-deficient mice. Cell 84, 551-562 (1996).
14. Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923-930 (1996).
15. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186, 2057-2062 (1997).
16. Nikolic, Z. J. & Carbone, F. R. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restrictedovalbumin determinant. Eur. J. Immunol. 20, 2431-2437 (1990).
17. Mackay, C. R. Homing of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5, 423-427 (1993).
18. Duckett, C. S. & Thompson, C. B. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signalling and the control of cell survival. Genes Dev. 11, 2810-2821 (1997).
19. Bevan, M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288 (1976).
20. Jondel, M., Schirmbeck, R. & Reimann, J. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302 (1998).
21. Vella, A. T., McCormack, J. E., Linsley, P. S., Kappler, J. W. & Marrack, P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2, 261-270 (1995).
22. Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
23. Bertolino, P. et al. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur. J. Immunol. 15, 1932-1942 (1995).